Extensively hydrolysed casein formula supplemented with Lactobacillus rhamnosus GG maintains hypoallergenic status: randomised double-blind, placebo-controlled crossover trial.
about
Gut microbiota as potential therapeutic target for the treatment of cow's milk allergyLong-term safety assessment in children who received hydrolyzed protein formulas with Lactobacillus rhamnosus GG: a 5-year follow-up.Cow's milk allergy: from allergens to new forms of diagnosis, therapy and prevention.The Potential Therapeutic Efficacy of Lactobacillus GG in Children with Food AllergiesA synbiotic-containing amino-acid-based formula improves gut microbiota in non-IgE-mediated allergic infants.Probiotics as treatment for food allergies among pediatric patients: a meta-analysis
P2860
Extensively hydrolysed casein formula supplemented with Lactobacillus rhamnosus GG maintains hypoallergenic status: randomised double-blind, placebo-controlled crossover trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Extensively hydrolysed casein ...... bo-controlled crossover trial.
@ast
Extensively hydrolysed casein ...... bo-controlled crossover trial.
@en
type
label
Extensively hydrolysed casein ...... bo-controlled crossover trial.
@ast
Extensively hydrolysed casein ...... bo-controlled crossover trial.
@en
prefLabel
Extensively hydrolysed casein ...... bo-controlled crossover trial.
@ast
Extensively hydrolysed casein ...... bo-controlled crossover trial.
@en
P2093
P2860
P1433
P1476
Extensively hydrolysed casein ...... bo-controlled crossover trial.
@en
P2093
Antonella Muraro
Carlos Lifschitz
Cheryl Harris
Deolinda M F Scalabrin
Jennifer L Wampler
Maarten O Hoekstra
Yolanda Meijer
P2860
P304
P356
10.1136/BMJOPEN-2011-000637
P577
2012-03-05T00:00:00Z